|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Patento numeris | 3310386 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16815196.7 |
| Europos patento paraiškos padavimo data | 2016-06-22 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-04-25 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/038702 |
| Data | 2016-06-22 |
| (87) | Numeris | WO 2016/209921 |
| Data | 2016-12-29 |
| (30) | Numeris | Data | Šalis |
| 201562182699 P | 2015-06-22 | US | |
| 201662319036 P | 2016-04-06 | US |
| (72) |
DOSHI, Parul , US
LOKHORST, Henk, M. , NL
MUTIS, Tuna , NL
|
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (54) | COMBINATION THERAPIES FOR HEME MALIGNANCIES WITH ANTI-CD38 ANTIBODIES AND SURVIVIN INHIBITORS |
| COMBINATION THERAPIES FOR HEME MALIGNANCIES WITH ANTI-CD38 ANTIBODIES AND SURVIVIN INHIBITORS |